【维升药业登陆港交所 】3月21日,维升药业在港交所主板上市,联席保荐人为摩根士丹利和杰富瑞。维升药业此次全球发售股份数目为1138.5万股,其中香港发售股份数目为455.4万股,国际发售股份数目为683.1万股,最终发售价为68.8港元/股。

金融界
21 Mar
3月21日,维升药业在港交所主板上市,联席保荐人为摩根士丹利杰富瑞。维升药业此次全球发售股份数目为1138.5万股,其中香港发售股份数目为455.4万股,国际发售股份数目为683.1万股,最终发售价为68.8港元/股。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10